REIN THERAPEUTICS INC (RNTX) Stock Analyst Ratings
USA - NASDAQ:RNTX - US00887A2042 - Common Stock
1.45 USD
-0.04 (-2.68%)
1.41 USD
-0.04 (-2.76%)
ChartMill assigns a Buy % Consensus number of 80% to RNTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 10.2. This target is 603.45% above the current price.
RNTX was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about RNTX.
In the previous month the buy percentage consensus was at a similar level.
RNTX was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-22 | HC Wainwright & Co. | Initiate | Buy |
| 2025-08-19 | Brookline Capital | Downgrade | Buy -> Hold |
REIN THERAPEUTICS INC / RNTX FAQ
Can you provide the average price target for REIN THERAPEUTICS INC stock?
8 analysts have analysed RNTX and the average price target is 10.2 USD. This implies a price increase of 603.45% is expected in the next year compared to the current price of 1.45.
Can you provide the consensus rating for REIN THERAPEUTICS INC stock?
The consensus rating for REIN THERAPEUTICS INC (RNTX) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.